Trading Signals: AUTL Stock Price Prediction and Forecast (Fri. Jun. 22, 2018 - Fri. May. 13, 2022)(Autolus Therapeutics plc )
| AUTL latest price $5.8850 (-3.92%) ($5.8850 - $5.8850) on Fri. Aug. 13, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.01% (three month average) | RSI | 60 | Latest Price | $5.8850(-3.92%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | AUTL declines -0.7% a day on average for past five trading days. | Weekly Trend | AUTL advances 5.7% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support AUTL advance at 0% a week (0% probability) XBI(55%) ARKG(50%) ARKK(49%) IWO(49%) ACES(48%) | Factors Impacting AUTL price | AUTL will decline at least -2.005% in a week (0% probabilities). VIXM(-32%) VXX(-31%) SHY(-19%) TLT(-17%) XLU(-14%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.005% (StdDev 4.01%) | Hourly BBV | -1.4 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $6.05(-2.73%) | 10 Day Moving Average | $5.95(-1.09%) | 20 Day Moving Average | $5.82(1.12%) | To recent high | -25.9% | To recent low | 10.7% | Market Cap | $307m | | | | Autolus Therapeutics Plc is a biopharmaceutical company. It engages in the development of cancer treatments. The firm's portfolio includes B Cell Malignancies, Multiple Myeloma, T Cell Lymphoma, GD2+ Tumors, and Prostate Cancer. The company was founded by Martin Pulé in February 2018 and is headquartered in London, the United Kingdom. |